Loading
One of the first HER2 gene tests, approved in December 1998 to select trastuzumab for breast cancer.
Abbott Molecular's PathVysion HER-2 DNA Probe Kit was approved on 11 December 1998 (PMA P980024) and is listed by the FDA as a companion diagnostic for trastuzumab in breast cancer, detecting HER2 gene amplification.
Fluorescence in situ hybridisation counting copies of the HER2 (ERBB2) gene in breast tumour cells. Connects to HER2.
| Region | Year | Indication |
|---|---|---|
| US | 1998 | HER2 gene amplification to select trastuzumab in breast cancer |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"PathVysion HER-2 DNA Probe Kit" OR ABSTRACT:"PathVysion HER-2 DNA Probe Kit") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about PathVysion HER-2 DNA Probe Kit, not a curated reading list.
Shares HER2-positive (IHC 3+ or ISH-amplified), HER2 IHC and ISH companion assays (HercepTest, PATHWAY 4B5, HER2 Dual ISH), Companion diagnostic, Companion diagnostics and the tag test.
Shares Abbott Laboratories, Companion diagnostic, Cytogenetics and FISH, FISH / ISH (in situ hybridisation) and the tag test.
Shares Abbott Laboratories, Companion diagnostic, Cytogenetics and FISH, FISH / ISH (in situ hybridisation) and the tag test.
Shares Abbott Laboratories, Companion diagnostic, Companion diagnostics and the tag test.
Shares Abbott Laboratories, Cytogenetics and FISH, FISH / ISH (in situ hybridisation) and the tag test.
Shares Abbott Laboratories, Companion diagnostic, Companion diagnostics and the tag test.
Shares Companion diagnostic, Companion diagnostics, HER2 and the tag test.
Shares Companion diagnostic, Companion diagnostics and the tag test.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/